Guangxu Xiao
State Key Laboratory Of Component Based Chinese Medicine, Beihua South Road
Jinghai, 301617, China
Jinghai, 301617, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Corrigendum to "Protection of Stroke-induced Blood-Brain Barrier Disruption by Guanxinning Injection and Its Active-component Combination via TLR4/NF-κB/MMP9-mediated Neuroinflammation" [Phytomedicine. 2025 Nov; 147:157162].
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 26, 2026
Mechanisms and therapeutic potential of microglia-regulated remyelination in chronic cerebral hypoperfusion.
Journal: Experimental neurology
Published: May 28, 2026
Senkyunolide I and Danshensu in combination ameliorate post-MI myocardial fibrosis by regulating TGF-β1/PAI-1 in mice and heart organoids.
Journal: Frontiers in pharmacology
Published: April 22, 2026
TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndrome.
Journal: Frontiers in immunology
Published: September 21, 2025
Buyang Huanwu decoction promotes post-stroke white matter repair via TREM2-Dependent microglial phagocytosis and IGF1 secretion.
Journal: Journal of ethnopharmacology
Published: July 10, 2025
Protection against stroke-induced blood-brain barrier disruption by Guanxinning injection and its active-component combination via TLR4/NF-κB/MMP9-mediated neuroinflammation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 20, 2025
Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids.
Journal: Frontiers in pharmacology
Published: September 05, 2024
Heart-brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential.
Journal: Frontiers in cardiovascular medicine
Published: October 07, 2023
Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38/FOS/MMP1-mediated inhibition of myocardial hypertrophy and fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 01, 2023
QiShen YiQi and its components attenuate acute thromboembolic stroke and carotid thrombosis by inhibition of CD62P/PSGL-1-mediated platelet-leukocyte aggregate formation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 05, 2022
Brain Microvascular Endothelial Cell-Derived Exosomes Protect Neurons from Ischemia-Reperfusion Injury in Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 26, 2022
CXCR1 and its downstream NF-κB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury.
Journal: Frontiers in immunology
Published: July 30, 2022
Last Updated: 09/26/2026